(Q43616090)

25 November 2017

title

An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy (English)

1 reference

25 November 2017

main subject

extrapyramidal symptoms

1 reference

Crocker AD

1

1 reference

25 November 2017

Hemsley KM

series ordinal

2

1 reference

25 November 2017

language of work or name

1 reference

1 April 2001

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

25 November 2017

published in

1 reference

25 November 2017

volume

25

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

573-590

1 reference

Motor and mental aspects of acute extrapyramidal syndromes.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

A new view of the role of dopamine receptors in the regulation of muscle tone

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Quantitative electromyographic changes following modification of central dopaminergic transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Distinct sites of functional interaction between dopamine, acetylcholine and gamma-aminobutyrate within the neostriatum: an electromyographic study in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

The effects of an irreversible dopamine receptor antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), on the regulation of muscle tone in the rat: the role of the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Raclopride and chlorpromazine, but not clozapine, increase muscle rigidity in the rat: relationship with D2 dopamine receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Neuroleptic binding to sigma receptors: possible involvement in neuroleptic-induced acute dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900176-7

7 January 2021

10.1016/S0278-5846(00)00176-7

Identifiers

DOI

1 reference

25 November 2017

1 reference